In summary, the studies herein reveal the differential molecular, cellular, and in vivo impact of distinct R273-p53 mutants in cancer (Fig. 7E) and lay the foundation for discerning the role of the relevant R273C-p53 mutant in conferring poor outcome. This evidence concerns the gene TP53 and cancer.